Search research articles
Contact Us
Filters
Showing results (31-40 of 42) with videos related to
Page
of 5
Sort By:
Journal of Crohn'S & Colitis
|
April 29, 2017
Incidence and Phenotype at Diagnosis of Very-early-onset Compared with Later-onset Paediatric Inflammatory Bowel Disease: A Population-based Study [1988-2011]
E Bequet, H Sarter, M Fumery, et al.
Alimentary Pharmacology & Therapeutics
|
April 15, 2011
The changing pattern of Crohn's disease incidence in northern France: a continuing increase in the 10- to 19-year-old age bracket (1988-2007)
V Chouraki, G Savoye, L Dauchet, et al.
Alimentary Pharmacology & Therapeutics
|
July 2, 2014
Factors associated with pregnancy outcome in anti-TNF treated women with inflammatory bowel disease
M Seirafi, B de Vroey, A Amiot, et al.
Journal of Crohn'S & Colitis
|
May 5, 2022
Comparative Risk of Incident Cancer in Patients with Inflammatory Bowel Disease with Prior Non-digestive Malignancy According to Immunomodulator: a Multicentre Cohort Study
F Poullenot, A Amiot, M Nachury, et al.
Journal of Crohn'S & Colitis
|
September 10, 2015
Fistula Plug in Fistulising Ano-Perineal Crohn's Disease: a Randomised Controlled Trial
A Senéjoux, L Siproudhis, L Abramowitz, et al.
Alimentary Pharmacology & Therapeutics
|
October 13, 2017
Cholangiopathy in critically ill patients surviving beyond the intensive care period: a multicentre survey in liver units
L Laurent, C Lemaitre, A Minello, et al.
Journal of Crohn'S & Colitis
|
September 24, 2020
Impact of an Education Programme on IBD Patients' Skills: Results of a Randomised Controlled Multicentre Study [ECIPE]
J Moreau, N Hammoudi, L Marthey, et al.
Alimentary Pharmacology & Therapeutics
|
September 10, 2014
Olmesartan-associated enteropathy: results of a national survey
L Marthey, G Cadiot, P Seksik, et al.
Alimentary Pharmacology & Therapeutics
|
June 9, 2017
One-year effectiveness and safety of vedolizumab therapy for inflammatory bowel disease: a prospective multicentre cohort study
A Amiot, M Serrero, L Peyrin-Biroulet, et al.
Alimentary Pharmacology & Therapeutics
|
December 19, 2017
Impact of vedolizumab therapy on extra-intestinal manifestations in patients with inflammatory bowel disease: a multicentre cohort study nested in the OBSERV-IBD cohort
S Tadbiri, L Peyrin-Biroulet, M Serrero, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 42) with videos related to
Sort By:
Page
of 5
Journal of Crohn'S & Colitis
|
April 29, 2017
Incidence and Phenotype at Diagnosis of Very-early-onset Compared with Later-onset Paediatric Inflammatory Bowel Disease: A Population-based Study [1988-2011]
E Bequet, H Sarter, M Fumery, et al.
Alimentary Pharmacology & Therapeutics
|
April 15, 2011
The changing pattern of Crohn's disease incidence in northern France: a continuing increase in the 10- to 19-year-old age bracket (1988-2007)
V Chouraki, G Savoye, L Dauchet, et al.
Alimentary Pharmacology & Therapeutics
|
July 2, 2014
Factors associated with pregnancy outcome in anti-TNF treated women with inflammatory bowel disease
M Seirafi, B de Vroey, A Amiot, et al.
Journal of Crohn'S & Colitis
|
May 5, 2022
Comparative Risk of Incident Cancer in Patients with Inflammatory Bowel Disease with Prior Non-digestive Malignancy According to Immunomodulator: a Multicentre Cohort Study
F Poullenot, A Amiot, M Nachury, et al.
Journal of Crohn'S & Colitis
|
September 10, 2015
Fistula Plug in Fistulising Ano-Perineal Crohn's Disease: a Randomised Controlled Trial
A Senéjoux, L Siproudhis, L Abramowitz, et al.
Alimentary Pharmacology & Therapeutics
|
October 13, 2017
Cholangiopathy in critically ill patients surviving beyond the intensive care period: a multicentre survey in liver units
L Laurent, C Lemaitre, A Minello, et al.
Journal of Crohn'S & Colitis
|
September 24, 2020
Impact of an Education Programme on IBD Patients' Skills: Results of a Randomised Controlled Multicentre Study [ECIPE]
J Moreau, N Hammoudi, L Marthey, et al.
Alimentary Pharmacology & Therapeutics
|
September 10, 2014
Olmesartan-associated enteropathy: results of a national survey
L Marthey, G Cadiot, P Seksik, et al.
Alimentary Pharmacology & Therapeutics
|
June 9, 2017
One-year effectiveness and safety of vedolizumab therapy for inflammatory bowel disease: a prospective multicentre cohort study
A Amiot, M Serrero, L Peyrin-Biroulet, et al.
Alimentary Pharmacology & Therapeutics
|
December 19, 2017
Impact of vedolizumab therapy on extra-intestinal manifestations in patients with inflammatory bowel disease: a multicentre cohort study nested in the OBSERV-IBD cohort
S Tadbiri, L Peyrin-Biroulet, M Serrero, et al.
Page
of 5